Intranasal delivery of calcitonin gene-related peptide reduces cerebral vasospasm in rats

Frontiers in Bioscience - Elite

Volumn 2 E, Issue 4, 2010, Pages 1502-1513

  Sun, Bao Liang ^a   Shen, Fa Ping ^a,b   Wu, Qing Jian ^a,c   Chi, Shu Mei ^a,d   Yang, Ming Feng ^a   Yuan, Hui ^a   Xie, Fang Min ^a,e   Zhang, Yan Bo ^a   Chen, Jun ^f   Zhang, Feng ^f  

^a Department of Neurology   (China)

^b General Hospital of Daqing Oil Field   (China)

^c JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^d Binzhou Central Hospital   (China)

^e SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

CEC; Cerebral vasospasm; CGRP; SAH; Vasodilator; VEGF

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; MESSENGER RNA; PRIMER DNA; VASCULOTROPIN A;

ANIMAL; ARTICLE; BRAIN VASOSPASM; DISEASE MODEL; GENETIC TRANSCRIPTION; GENETICS; IMMUNOHISTOCHEMISTRY; INTRANASAL DRUG ADMINISTRATION; MALE; METABOLISM; NUCLEOTIDE SEQUENCE; RAT; WESTERN BLOTTING; WISTAR RAT;

ADMINISTRATION, INTRANASAL; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CALCITONIN GENE-RELATED PEPTIDE; DISEASE MODELS, ANIMAL; DNA PRIMERS; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASOSPASM, INTRACRANIAL;

EID: 77957327217     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e209     Document Type: Article

References (53)

1. J. van Gijn, R. S. Kerr and G. J. Rinkel: Subarachnoid haemorrhage. Lancet, 369(9558), 306-18 (2007) (Pubitemid 46136491)
2. J. W. Hop, G. J. Rinkel, A. Algra and J. van Gijn: Casefatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke, 28(3), 660-4 (1997) (Pubitemid 27118394)
3. J. Cahill, J. W. Calvert and J. H. Zhang: Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab, 26(11), 1341-53 (2006) (Pubitemid 44629883)
4. G. J. Kaptain, G. Lanzino and N. F. Kassell: Subarachnoid haemorrhage: epidemiology, risk factors, and treatment options. Drugs Aging, 17(3), 183-99 (2000)
5. R. D. Rothoerl and F. Ringel: Molecular mechanisms of cerebral vasospasm following aneurysmal SAH. Neurol Res, 29(7), 636-42 (2007) (Pubitemid 350086058)
6. A. G. Kolias, J. Sen and A. Belli: Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. J Neurosci Res, 87(1), 1-11 (2009)
7. R. H. Wilkins: Cerebral vasospasm. Crit Rev Neurobiol, 6(1), 51-77 (1990) (Pubitemid 20320179)
8. R. Iwai, K. Kamiyama, T. Nagahori, T. Ohtsuji, S. Endo and A. Takaku: Relation of supersensitivity to cerebral vasospasm induced by oxyhaemoglobin. Neurol Res, 10(3), 169-74 (1988)
9. S. D. Brain, T. J. Williams, J. R. Tippins, H. R. Morris and I. MacIntyre: Calcitonin gene-related peptide is a potent vasodilator. Nature, 313(5997), 54-6 (1985) (Pubitemid 15192304)
10. S. G. Amara, V. Jonas, M. G. Rosenfeld, E. S. Ong and R. M. Evans: Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature, 298(5871), 240-4 (1982) (Pubitemid 12089405)
11. J. K. Lennerz, V. Ruhle, E. P. Ceppa, W. L. Neuhuber, N. W. Bunnett, E. F. Grady and K. Messlinger: Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1(RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol, 507(3), 1277-99 (2008) (Pubitemid 351413572)
12. R. Uddman, L. Edvinsson, R. Ekman, T. Kingman and J. McCulloch: Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: Trigeminal origin and co-existence with substance P. Neuroscience Letters, 62(1), 131-136 (1985) (Pubitemid 16205735)
13. T. P. O'Connor and D. van der Kooy: Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J. Neurosci., 8(7), 2468-2476 (1988)
14. C. Juaneda, Y. Dumont and R. Quirion: The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends in Pharmacological Sciences, 21(11), 432-438 (2000)
15. L. Edvinsson, R. Juul and I. Jansen: Perivascular neuropeptides (NPY, VIP, CGRP and SP) in human brain vessels after subarachnoid haemorrhage. Acta Neurol Scand, 90(5), 324-30 (1994) (Pubitemid 24363260)
16. S. D. Brain and A. D. Grant: Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev, 84(3), 903-34 (2004) (Pubitemid 38823770)
17. C. Arienta, S. Balbi, M. Caroli and G. Fumagalli: Depletion of calcitonin gene-related peptide in perivascular nerves during acute phase of posthemorrhagic vasospasm in the rabbit. Brain Res Bull, 27(5), 605-9 (1991)
18. K. Nozaki, Y. Uemura, S. Okamoto, H. Kikuchi and N. Mizuno: Relaxant effect of calcitonin gene-related peptide on cerebral arterial spasm induced by experimental subarachnoid hemorrhage in dogs. J Neurosurg, 71(4), 558-64 (1989) (Pubitemid 19244273)
19. S. Imaizumi, H. Shimizu, I. Ahmad, T. Kaminuma, M. Tajima and T. Yoshimoto: Effect of calcitonin gene-related peptide on delayed cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Surg Neurol, 46(3), 263-70; discussion 270-1 (1996)
20. K. Toyoda, F. M. Faraci, A. F. Russo, B. L. Davidson and D. D. Heistad: Gene transfer of calcitonin gene-related peptide to cerebral arteries. Am J Physiol Heart Circ Physiol, 278(2), H586-94 (2000) (Pubitemid 30131260)
21. K. Toyoda, F. M. Faraci, Y. Watanabe, T. Ueda, J. J. Andresen, Y. Chu, S. Otake and D. D. Heistad: Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage. Circ Res, 87(9), 818-24 (2000)
22. R. Juul, S. Aakhus, K. Bjornstad, S. E. Gisvold, A. O. Brubakk and L. Edvinsson: Calcitonin gene-related peptide (human alpha-CGRP) counteracts vasoconstriction in human subarachnoid haemorrhage. Neurosci Lett, 170(1), 67-70 (1994) (Pubitemid 24117288)
23. L. Edvinsson, E. Nilsson and I. Jansen-Olesen: Inhibitory effect of BIBN4096BS, CGRP (8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery. Br J Pharmacol, 150(5), 633-40 (2007) (Pubitemid 46355559)
24. L. R. Hanson and W. H. Frey, 2nd: Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS. J Neuroimmune Pharmacol, 2(1), 81-6 (2007)
25. L. Fletcher, S. Kohli, S. M. Sprague, R. A. Scranton, S. A. Lipton, A. Parra, D. F. Jimenez and M. Digicaylioglu: Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation. J Neurosurg, 111(1), 164-70 (2009)
26. G. Wei, D. Wang, H. Lu, S. Parmentier, Q. Wang, S. S. Panter, W. H. Frey, 2nd and W. Ying: Intranasal administration of a PARG inhibitor profoundly decreases ischemic brain injury. Front Biosci, 12, 4986-96 (2007)
27. K. P. Doyle, T. Yang, N. S. Lessov, T. M. Ciesielski, S. L. Stevens, R. P. Simon, J. S. King and M. P. Stenzel-Poore: Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke. J Cereb Blood Flow Metab, 28(6), 1235-1248 (2008) (Pubitemid 351733347)
28. M. C. Veronesi, D. J. Kubek and M. J. Kubek: Intranasal delivery of a thyrotropin-releasing hormone analog attenuates seizures in the amygdala-kindled rat. Epilepsia, 48(12), 2280-6 (2007) (Pubitemid 350243399)
29. L. Xu, N. Rensing, X. F. Yang, H. X. Zhang, L. L. Thio, S. M. Rothman, A. E. Weisenfeld, M. Wong and K. A. Yamada: Leptin inhibits 4-aminopyridine-and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents. J Clin Invest, 118(1), 272-80 (2008)
30. M. A. Reger, G. S. Watson, P. S. Green, L. D. Baker, B. Cholerton, M. A. Fishel, S. R. Plymate, M. M. Cherrier, G. D. Schellenberg, W. H. Frey, 2nd and S. Craft: Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis, 13(3), 323-31 (2008) (Pubitemid 352039034)
31. I. Gozes, A. Bardea, A. Reshef, R. Zamostiano, S. Zhukovsky, S. Rubinraut, M. Fridkin and D. E. Brenneman: Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. Proc Natl Acad Sci U S A, 93(1), 427-32 (1996) (Pubitemid 26041486)
32. B. L. Sun, H. Yuan, M. F. Yang, Z. L. Xia, S. M. Zhang and L. X. Wang: Effects of extract of ginkgo biloba on intracranial pressure, cerebral perfusion pressure, and cerebral blood flow in a rat model of subarachnoid haemorrhage. Int J Neurosci, 117(5), 655-65 (2007) (Pubitemid 46673512)
33. B. L. Sun, C. B. Zheng, M. F. Yang, H. Yuan, S. M. Zhang and L. X. Wang: Dynamic alterations of cerebral pial microcirculation during experimental subarachnoid hemorrhage. Cell Mol Neurobiol, 29(2), 235-41 (2009)
34. R. G. Thorne, C. R. Emory, T. A. Ala and W. H. Frey Ii: Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Research, 692(1-2), 278-282 (1995)
35. H. Suzuki, K. Kanamaru, H. Tsunoda, H. Inada, M. Kuroki, H. Sun, S. Waga and T. Tanaka: Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J Clin Invest, 104(1), 59-66 (1999) (Pubitemid 29534345)
36. F. Zhang, S. Wang, Y. Luo, X. Ji, E. M. Nemoto and J. Chen: When hypothermia meets hypotension and hyperglycemia: the diverse effects of adenosine 5'-monophosphate on cerebral ischemia in rats. J Cereb Blood Flow Metab, 29(5), 1022-34 (2009)
37. F. Zhang, L. Zhou, F. Huang, Y. Liang and G. Zhang: U-74389G suppresses lipid peroxidation and apoptosis following focal cerebral ischemia and reperfusion in rats. Chin Med J (Engl), 111(9), 838-41 (1998) (Pubitemid 28425592)
38. I. Solaroglu, T. Tsubokawa, J. Cahill and J. H. Zhang: Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience, 143(4), 965-74 (2006) (Pubitemid 44827523)
39. J. Hladovec: The effect of some platelet aggregating and potential thrombosis-promoting substances on the development of experimental arterial thrombosis. Thromb Diath Haemorrh, 29(1), 196-200 (1973)
40. U. Erdbruegger, M. Haubitz and A. Woywodt: Circulating endothelial cells: A novel marker of endothelial damage. Clinica Chimica Acta, 373(1-2), 17-26 (2006) (Pubitemid 44292176)
41. J.-Y. Lee, Y. He, O. Sagher, R. Keep, Y. Hua and G. Xi: Activated autophagy pathway in experimental subarachnoid hemorrhage. Brain Research, 1287, 126-135 (2009)
42. S. Park, M. Yamaguchi, C. Zhou, J. W. Calvert, J. Tang and J. H. Zhang: Neurovascular Protection Reduces Early Brain Injury After Subarachnoid Hemorrhage. Stroke, 35(10), 2412-2417 (2004) (Pubitemid 39311273)
43. A. Y. Zubkov, K. Ogihara, D. H. Bernanke, A. D. Parent and J. Zhang: Apoptosis of endothelial cells in vessels affected by cerebral vasospasm. Surg Neurol, 53(3), 260-6 (2000) (Pubitemid 30201532)
44. Y. L. Dong, D. M. Reddy, K. E. Green, M. S. Chauhan, H. Q. Wang, M. Nagamani, G. D. Hankins and C. Yallampalli: Calcitonin gene-related peptide (CALCA) is a proangiogenic growth factor in the human placental development. Biol Reprod, 76(5), 892-9 (2007) (Pubitemid 46651230)
45. M. Toda, T. Suzuki, K. Hosono, I. Hayashi, S. Hashiba, Y. Onuma, H. Amano, Y. Kurihara, H. Kurihara, H. Okamoto, S. Hoka and M. Majima: Neuronal systemdependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide. Proc Natl Acad Sci U S A, 105(36), 13550-5 (2008)
46. F. Y. Sun and X. Guo: Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J Neurosci Res, 79(1-2), 180-4 (2005) (Pubitemid 40116433)
47. S. Erik, L. Diether and C. Peter: VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. BioEssays, 26(9), 943-954 (2004)
48. T. Nakayama, K. Illoh, C. Ruetzler, S. Auh, L. Sokoloff and J. Hallenbeck: Intranasal administration of E-selectin to induce immunological tolerization can suppress subarachnoid hemorrhage-induced vasospasm implicating immune and inflammatory mechanisms in its genesis. Brain Res, 1132(1), 177-84 (2007) (Pubitemid 46096439)
49. C. B. Bunker, C. Reavley, D. J. O'Shaughnessy and P. M. Dowd: Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon. Lancet, 342(8863), 80-3 (1993) (Pubitemid 23192424)
50. H. Doods, K. Arndt, K. Rudolf and S. Just: CGRP antagonists: unravelling the role of CGRP in migraine. Trends in Pharmacological Sciences, 28(11), 580-587 (2007) (Pubitemid 350026615)
51. J. Josko: Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats. Brain Res, 981(1-2), 58-69 (2003) (Pubitemid 37281220)
52. G. Neufeld, T. Cohen, S. Gengrinovitch and Z. Poltorak: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J., 13(1), 9-22 (1999) (Pubitemid 29038270)
53. S. K. Nadar, G. Y. Lip, K. W. Lee and A. D. Blann: Circulating endothelial cells in acute ischaemic stroke. Thromb Haemost, 94(4), 707-12 (2005) (Pubitemid 41489228)